The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
Norges Bank has divested from a major traditional Chinese medicine (TCM) company in the wake of EIA’s major exposé Investing in Extinction, which found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 products. The bank cited an ‘unacceptable risk’ of Tianjin Pharmaceutical Da Re Tang Group Corp […]
Illegal wildlife trade is happening on a large scale to supply the parts and products of protected species such as leopards, pangolins, rhinos and tigers to serve as ingredients in some traditional Chinese medicines – and some big international household names are invested
A new EIA UK investigation has found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 traditional Chinese medicine (TCM) products Manufactured by 72 Chinese companies and licensed by the National Medical Products Administration of China, some of those identified also contain tiger and rhino, in contravention of […]
China’s failure to do enough to prevent the illegal trade in endangered pangolins is damaging the effectiveness of a key international wildlife treaty, the US Department of the Interior has announced.
As China’s amended Wildlife Protection Law comes into effect, EIA reiterates its concerns about the law’s encouragement and allowance of the utilisation of threatened wild animals for commercial purposes